目的探讨如何建立我国的药品不良反应救济制度。方法通过一对一问卷调查我国民众对建立药品不良反应救济制度的态度、救济模式。结果在被调查者中91.80%的人认为出现ADR后应该救济,而89.33%的人认为有必要建立我国的ADR救济制度;认为可通过购买保险方式进行救济的77.74%,愿意购买该类型的保险的占73.59%;被调查者按年度定期买救济保险20元/年以下占79.28%,按诊疗次数买救济保险,门诊1元/次以下占83.62%。住院10元/次以下占82.55%。结论大部分被调查者认为严重的ADR应得到救济;大部分被调查者愿意购买保险,我国建立以政府救济基金为主,商业保险为辅的救济模式理论上是可行的。 Objective To explore how to establish China’s system of adverse drug reaction relief. Methods One-on-one questionnaires were used to investigate the attitudes and relief patterns of people in our country on the establishment of adverse drug reaction relief system. As a result, 91.80% of respondents believed that ADR should be relieved, while 89.33% thought it was necessary to set up our country’s ADR relief system. They thought that 77.74% of the remedies could be purchased by insurance and would like to buy this type of insurance Accounted for 73.59% of respondents; the respondents regularly bought relief insurance at an annual rate of 20 yuan / year, accounting for 79.28%. The number of treatment visits was relief insurance and the number of outpatients was below 1 yuan / time, accounting for 83.62%. Hospitalization of 10 yuan / times or less accounted for 82.55%. Conclusion Most respondents think that serious ADR should be relieved. Most respondents are willing to buy insurance. In our country, it is theoretically feasible to set up a remedy mode based on government relief fund and supplemented by commercial insurance.